Healthcare · Medical - Instruments & Supplies
Price
$12.26
Market Cap
$2.5B
Employees
14,250
Beta
0.89
Avg Volume
5,468,160
CEO
Daniel T. Scavilla
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
Runs with full report
Price Overview
Last updated: Jul 13, 2026 5:44am (just now)
Current data · timestamped when a report runs
$12.26
Change · Jul 13
+0.37 (+3.11%)
Day Range
$11.76 – $12.38
52-Week Range
$9.41 – $17.09
50-Day MA
$10.65
200-Day MA
$11.74
Volume
4,690,420.00
Analyst Price Targets
Low
$9.00
Consensus
$13.00
High
$17.00
(27 analysts)
Share Structure
Outstanding
200,326,683.00
Float
199,220,880.00
Free Float
99.4%
High free float
— 99.4% of shares trade freely, ~0.6% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-4.09
Stock Price: $12.26
EPS (Diluted): -3.00
EPS (Diluted): -3.00
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
1.70
Stock Price: $12.26
Total Equity: $1.34B
Shares: 199,400,000
Total Equity: $1.34B
Shares: 199,400,000
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-36.20
Market Cap: $2.46B
Total Debt: $2.38B
Cash: $326.00M
EBITDA: -$46.00M
Total Debt: $2.38B
Cash: $326.00M
EBITDA: -$46.00M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$4.4B
Market Cap: $2.46B
Total Debt: $2.38B
Cash: $326.00M
Total Debt: $2.38B
Cash: $326.00M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
0.62
Stock Price: $12.26
Revenue: $3.68B
Shares: 199,400,000
Revenue: $3.68B
Shares: 199,400,000
EV/Sales (Total value vs revenue — works when P/E can't)
API1.20
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
50.0%
Gross Profit: $1.84B
Revenue: $3.68B
Revenue: $3.68B
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
6.8%
Operating Income: $252.00M
Revenue: $3.68B
Revenue: $3.68B
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-16.3%
Net Income: -$598.00M
Revenue: $3.68B
Revenue: $3.68B
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-41.2%
Net Income: -$598.00M
Total Equity: $1.34B
Total Equity: $1.34B
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
5.1%
Operating Income: $252.00M
Tax Rate: -23.0%
Equity: $1.34B
Total Debt: $2.38B
Cash: $326.00M
Tax Rate: -23.0%
Equity: $1.34B
Total Debt: $2.38B
Cash: $326.00M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
1.51
Current Assets: $2.02B
Current Liabilities: $1.34B
Current Liabilities: $1.34B
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
1.77
Short-Term Debt: $360.00M
Long-Term Debt: $2.02B
Total Debt: $2.38B
Total Equity: $1.34B
Long-Term Debt: $2.02B
Total Debt: $2.38B
Total Equity: $1.34B
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$18.46
Revenue: $3.68B
Shares: 199,400,000
Shares: 199,400,000
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$6.72
Total Equity: $1.34B
Shares: 199,400,000
Shares: 199,400,000
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$0.52
Operating CF: $235.00M
CapEx: -$131.00M
Shares: 199,400,000
CapEx: -$131.00M
Shares: 199,400,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
5.6%
Last Dividend: N/A
Stock Price: $12.26
Stock Price: $12.26
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$598.00M
Net Income: -$598.00M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares XRAY against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jul 13, 2026 5:44am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $4.2B | $3.9B | $4.0B | $3.8B | $3.7B |
| Cost of Revenue | $1.9B | $1.8B | $1.9B | $1.8B | $1.8B |
| Gross Profit | $2.3B | $2.1B | $2.1B | $2.0B | $1.8B |
| Operating Expenses | $1.7B | $3.1B | $2.2B | $2.8B | $1.6B |
| Operating Income | $608.0M | -$937.0M | -$85.0M | -$879.0M | $252.0M |
| Net Income | $411.0M | -$950.0M | -$132.0M | -$910.0M | -$598.0M |
| EBITDA | $952.0M | -$662.0M | $249.0M | -$518.0M | -$46.0M |
| EPS | $1.88 | $-4.41 | $-0.62 | $-4.48 | $-3.00 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jul 13, 2026 5:44am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $339.0M | $365.0M | $334.0M | $272.0M | $326.0M |
| Total Current Assets | $1.9B | $1.9B | $2.0B | $1.7B | $2.0B |
| Total Assets | $9.2B | $7.6B | $7.4B | $5.8B | $5.4B |
| Current Liabilities | $1.3B | $1.2B | $1.4B | $1.6B | $1.3B |
| Long-Term Debt | $1.9B | $1.8B | $1.8B | $1.6B | $2.0B |
| Total Liabilities | $4.2B | $3.8B | $4.1B | $3.8B | $4.1B |
| Total Equity | $5.0B | $3.8B | $3.3B | $1.9B | $1.3B |
| Retained Earnings | $1.5B | $456.0M | $205.0M | -$835.0M | -$1.6B |
Cash Flow (Annual)
Last updated: Jul 13, 2026 5:44am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $657.0M | $517.0M | $377.0M | $461.0M | $235.0M |
| Capital Expenditure | -$142.0M | -$149.0M | -$149.0M | -$180.0M | -$131.0M |
| Free Cash Flow | $515.0M | $368.0M | $228.0M | $281.0M | $104.0M |
| Acquisitions (net) | -$220.0M | $0 | $13.0M | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$200.0M | -$150.0M | -$300.0M | -$250.0M | $0 |
| Net Change in Cash | -$99.0M | $26.0M | -$31.0M | -$62.0M | $54.0M |
Analyst Estimates (Annual)
Last updated: Jul 13, 2026 5:44am (just now)| Metric | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| Revenue |
$3.6B $3.6B – $3.6B
|
$3.7B $3.6B – $3.7B
|
$3.7B $3.7B – $3.7B
|
$3.8B $3.7B – $3.8B
|
| EBITDA |
-$21.5M -$21.7M – -$21.4M
|
-$22.0M -$22.2M – -$21.6M
|
-$22.5M -$22.5M – -$22.5M
|
-$22.7M -$23.0M – -$22.4M
|
| Net Income |
$282.8M $278.9M – $286.8M
|
$311.7M $293.6M – $329.8M
|
$195.8M $43.3M – $569.4M
|
$342.0M $336.1M – $346.5M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jul 13, 2026 5:44am (just now)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | -7.3% | +1.1% | -4.3% | -3.0% |
| Gross Profit Growth | -9.4% | -1.9% | -6.1% | -6.0% |
| Operating Income Growth | -254.1% | +90.9% | -934.1% | +128.7% |
| Net Income Growth | -331.1% | +86.1% | -589.4% | +34.3% |
| EBITDA Growth | -169.5% | +137.6% | -308.0% | +91.1% |
Dividend History (Last 20)
Last updated: Jul 13, 2026 5:44am (just now)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2025-12-26 | $0.16 | 2025-12-10 | 2025-12-26 | 2026-01-09 |
| 2025-09-26 | $0.16 | 2025-07-31 | 2025-09-26 | 2025-10-10 |
| 2025-06-27 | $0.16 | 2025-05-21 | 2025-06-27 | 2025-07-11 |
| 2025-03-28 | $0.16 | 2025-02-27 | 2025-03-28 | 2025-04-11 |
| 2024-12-27 | $0.16 | 2024-12-13 | 2024-12-27 | 2025-01-10 |
| 2024-09-27 | $0.16 | 2024-07-29 | 2024-09-27 | 2024-10-11 |
| 2024-06-28 | $0.16 | 2024-05-22 | 2024-06-28 | 2024-07-12 |
| 2024-03-27 | $0.16 | 2024-02-29 | 2024-03-29 | 2024-04-12 |
| 2023-12-28 | $0.14 | 2023-12-21 | 2023-12-29 | 2024-01-12 |
| 2023-09-28 | $0.14 | 2023-08-02 | 2023-09-29 | 2023-10-13 |
| 2023-06-29 | $0.14 | 2023-05-24 | 2023-06-30 | 2023-07-14 |
| 2023-03-30 | $0.14 | 2023-02-28 | 2023-03-31 | 2023-04-14 |
| 2022-12-29 | $0.13 | 2022-12-15 | 2022-12-30 | 2023-01-13 |
| 2022-09-29 | $0.13 | 2022-08-04 | 2022-09-30 | 2022-10-14 |
| 2022-06-23 | $0.13 | 2022-05-27 | 2022-06-24 | 2022-07-08 |
| 2022-03-24 | $0.13 | 2022-02-23 | 2022-03-25 | 2022-04-08 |
| 2021-12-30 | $0.11 | 2021-12-16 | 2021-12-31 | 2022-01-14 |
| 2021-09-23 | $0.11 | 2021-08-04 | 2021-09-24 | 2021-10-08 |
| 2021-06-24 | $0.11 | 2021-05-27 | 2021-06-25 | 2021-07-09 |
| 2021-03-25 | $0.10 | 2021-02-24 | 2021-03-26 | 2021-04-09 |
Insider Trading (Recent)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-30 | MAZELSKY JONATHAN JAY | A-Award | 2,841.83 | $0.00 | $0 |
| 2026-06-12 | MAZELSKY JONATHAN JAY | P-Purchase | 10,000.00 | $10.14 | $101,400 |
| 2026-06-08 | Barton-Brobst Lindi Rene | 0.00 | $0.00 | $0 | |
| 2026-06-08 | Barton-Brobst Lindi Rene | 0.00 | $0.00 | $0 | |
| 2023-11-09 | Barton-Brobst Lindi Rene | 500.00 | $51.40 | $25,700 | |
| 2024-03-04 | Barton-Brobst Lindi Rene | 1,600.00 | $58.71 | $93,936 | |
| 2025-03-03 | Barton-Brobst Lindi Rene | 1,600.00 | $53.30 | $85,280 | |
| 2026-03-03 | Barton-Brobst Lindi Rene | 2,400.00 | $38.74 | $92,976 | |
| 2026-05-04 | Barton-Brobst Lindi Rene | 1,400.00 | $40.85 | $57,190 | |
| 2026-06-08 | Barton-Brobst Lindi Rene | 18,000.00 | $14.78 | $266,040 | |
| 2026-06-08 | Barton-Brobst Lindi Rene | 556.72 | $0.00 | $0 | |
| 2026-06-15 | HOSEIN CLYDE | P-Purchase | 6,500.00 | $9.99 | $64,903 |
| 2026-06-12 | MCKEON BRIAN P | P-Purchase | 10,000.00 | $10.12 | $101,200 |
| 2026-06-15 | Gladden Brian T | P-Purchase | 9,985.02 | $10.02 | $100,000 |
| 2026-06-12 | MAZELSKY JONATHAN JAY | A-Award | 10,000.00 | $10.14 | $101,400 |
| 2026-06-11 | HOLDEN BETSY D | P-Purchase | 10,086.00 | $9.88 | $99,692 |
| 2026-06-11 | Barber Michael J | P-Purchase | 15,175.00 | $9.89 | $150,005 |
| 2026-06-03 | LUCIER GREGORY T | G-Gift | 38,382.00 | $0.00 | $0 |
| 2026-06-03 | LUCIER GREGORY T | A-Award | 38,382.00 | $0.00 | $0 |
| 2026-06-03 | LUCIER GREGORY T | A-Award | 10,900.00 | $9.64 | $105,076 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for XRAY — it's generated by the pipeline (
market-narrative step).
No community reviews yet for XRAY.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.419 · a47bea37 · 2026-07-12 16:28:07